Katsue Magari

FK506 potently inhibits T cell activation induced TNF‐α and IL‐1β production <i>in vitro</i> by human peripheral blood mononuclear cells

Shozo Sakuma, Yasuko Kato, Fusako Nishigaki et al. · British Journal of Pharmacology · 2000 · 92 citations · Full text

Tumour Necrosis Factor, Immunology, Immune Regulation +23

FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis

Shozo Sakuma, Fusako Nishigaki, Katsue Magari et al. · Inflammation Research · 2001 · 49 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro

Shozo Sakuma, Yasuko Kato, Fusako Nishigaki et al. · International Immunopharmacology · 2001 · 45 citations

Inflammation, Rheumatology, T Cell Activation +11

Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: Effect of FK506, an inhibitor of T cell activation

Katsue Magari, Shinji Miyata, Y. Ohkubo et al. · Inflammation Research · 2004 · 36 citations

Inflammation, Rheumatology, Cytokine +14

Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.

Katsue Magari, Susumu Miyata, Fusako Nishigaki et al. · PubMed · 2003 · 36 citations